How Preclinical CROs Are Now Using Future Technology To Conduct Health Research
Future technology is changing the world of health. As a result, new ways on how health research is conducted and performed are beginning to emerge. Major Contract Research Organizations or CROs are starting to employ AI in pre-clinical tests, thus revolutionizing the role of technology in healthcare.
Artificial intelligence is a type of intelligence displayed by machines and computer systems. Nowadays, there are several ways how pre-clinical CROs use AI in their studies. But, first, what are pre-clinical CROs?
Pre-clinical CRO Defined
Pre-clinical CROs, otherwise known as Pre-clinical Contract Research Organizations, are companies that provide knowledge, skills, and experience needed to transform a medical or pharmaceutical idea concept into a final product. There are a lot of processes involved before the final product is revealed, which include the discovery and development stage, pre-clinical research stage, the clinical research stage, and, lastly, the FDA review.
The period between pre-clinical tryouts and the unveiling of the product is where the role of a pre-clinical CRO is most critical. Drug ideas and prospective products may fail within this period; hence modern pre-clinical CROs, like Ion Channel CRO, continue to dig deeper into the capacity of future technology to increase efficiency in health research.
Reasons Why Pre-clinical CROS Are Using Future Technology/AI To Conduct Health Research
- Reduces uncertainty in pre-clinical experiments – AI is now being used to reduce the improbability that comes with pre-clinical trials. This will go a long way in reducing time spent on research, cutting down financial costs, and optimizing data gathering.
- Gathers data and obtains actionable insights – Researchers now use AI to streamline data collection and selection of recipients of pre-clinical tests. Data collection and analysis are an integral part of health research, and keeping up with the zillions of data available is impossible for the human researcher. However, with the aid of AI tools, such as deep learning and machine learning, it is possible to analyze, select patterns, and connect relevant data that can lead to drug discovery.
Researchers also make use of reports generated by AI to gain actionable insights during their pre-clinical studies. AI tools can also improve recipients’ selection by choosing the most appropriate group capable of responding to pre-clinical research and tests.